Abstract
Introduction The World Health Organisation’s Integrated Management of Childhood Illnesses (IMCI) algorithm relies on counting respiratory rate and observing respiratory distress to diagnose childhood pneumonia. IMCI performs with high sensitivity but low specificity, leading to over-diagnosis of child pneumonia and unnecessary antibiotic use. Including lung auscultation in IMCI could improve pneumonia diagnosis. Our objectives are: (i) assess lung sound recording quality by primary health care workers (HCWs) from under-five children with the Feelix Smart Stethoscope; and (ii) determine the reliability and performance of recorded lung sound interpretations by an automated algorithm compared to reference paediatrician interpretations.
Methods and analysis In a cross-sectional design, Community HCWs will record lung sounds of ∼1,000 under-five-year-old children with suspected pneumonia at first-level facilities in Zakiganj sub-district, Sylhet, Bangladesh. Enrolled children will be evaluated for pneumonia, including oxygen saturation, and have their lung sounds recorded by the Feelix Smart stethoscope at four sequential chest locations: two back and two front positions. A novel sound-filtering algorithm will be applied to recordings to address ambient noise and optimize recording quality. Recorded sounds will be assessed against a pre-defined quality threshold. A trained paediatric listening panel will classify recordings into one of the following categories: normal, crackle, wheeze, crackle and wheeze, or uninterpretable. All sound files will be classified into the same categories by the automated algorithm and compared with panel classifications.
Conclusions Lung auscultation and reliable interpretation of lung sounds of children are usually not feasible in first-level facilities in Bangladesh and other low- and middle-income countries (LMICs). Incorporating automated lung sound classification within the current IMCI pneumonia diagnostic algorithm may improve childhood pneumonia diagnostic accuracy at LMIC first-level facilities.
Ethics and dissemination Ethical review has been obtained in Bangladesh (BMRC Registration Number: 09630012018) and in Edinburgh, Scotland, United Kingdom (REC Reference: 18-HV-051). Dissemination will be through conference presentations, peer-reviewed journals and stakeholder engagement meetings in Bangladesh.
Trial registration number NCT03959956
Article summay Strengths and limitations of this study
Evaluating the quality of lung sound recordings in a first-level facility where auscultation is usually unavailable and challenging to obtain due to a typically crowded and noisy environment and providers may not get enough time to calm the child due to time pressure from a high-volume patient.
This study will assess the feasibility of recording lung sounds by front line community health workers who do not usually use conventional stethoscopes during clinical care.
Two standardised paediatricians masked to the child’s clinical status will independently classify the recorded lung sounds, and a third masked and independent paediatrician will arbitrate any discrepancies.
A machine-learning algorithm developed by Johns Hopkins and Sonavi Labs will detect abnormal lung sounds and be compared with classifications by human listeners/paediatricians.
The study will not have chest radiography findings of enrolled children, which is considered by many a gold standard for pneumonia diagnosis, as chest radiography is not available at this level of the health system in Bangladesh. Instead, this study will measure the peripheral oxyhaemoglobin saturation and evaluate clinical examination findings, including respiratory danger signs data.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the UK National Institute for Health Research (NIHR) (Global Health Research Unit on Respiratory Health (RESPIRE); 16/136/109) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Government. The RESPIRE collaboration comprises the UK Grant holders, Partners and research teams as listed on the RESPIRE website (www.ed.ac.uk/usher/respire).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval is obtained from the National Research Ethics Committee of Bangladesh Medical Research Council (BMRC), Bangladesh (Registration Number: 09630012018), and Academic and Clinical Central Office for Research and Development (ACCORD) Medical Research Ethics Committee (AMREC) NHS, Lothian, Edinburgh, UK (REC Reference: 18-HV-051).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Anonymised data files will also be stored securely in the DataStore repository at the University of Edinburgh, UK and will be shared after the publication of the main paper.